|
1
|
Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.
|
PLoS Biol
|
2005
|
2.08
|
|
2
|
Conditional immortalization of human B cells by CD40 ligation.
|
PLoS One
|
2008
|
1.89
|
|
3
|
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.
|
Proc Natl Acad Sci U S A
|
2006
|
1.81
|
|
4
|
Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.
|
PLoS Pathog
|
2010
|
1.80
|
|
5
|
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
|
Proc Natl Acad Sci U S A
|
2003
|
1.75
|
|
6
|
Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production.
|
J Immunol
|
2012
|
1.71
|
|
7
|
Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus.
|
J Cell Sci
|
2003
|
1.62
|
|
8
|
Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
|
Cancer Res
|
2003
|
1.56
|
|
9
|
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.
|
Blood
|
2007
|
1.50
|
|
10
|
CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
|
J Exp Med
|
2004
|
1.47
|
|
11
|
Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.
|
Oncogene
|
2005
|
1.47
|
|
12
|
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.
|
Proc Natl Acad Sci U S A
|
2009
|
1.46
|
|
13
|
Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.
|
J Virol
|
2002
|
1.36
|
|
14
|
Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins.
|
Proc Natl Acad Sci U S A
|
2008
|
1.36
|
|
15
|
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.
|
Blood
|
2010
|
1.35
|
|
16
|
CpG-methylation regulates a class of Epstein-Barr virus promoters.
|
PLoS Pathog
|
2010
|
1.28
|
|
17
|
Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
|
J Virol
|
2005
|
1.22
|
|
18
|
Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.
|
Blood
|
2005
|
1.18
|
|
19
|
The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.
|
PLoS Pathog
|
2012
|
1.08
|
|
20
|
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.
|
Blood
|
2002
|
1.08
|
|
21
|
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
|
J Virol
|
2004
|
1.06
|
|
22
|
A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.
|
J Virol
|
2005
|
1.03
|
|
23
|
Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
|
Eur J Cell Biol
|
2011
|
1.02
|
|
24
|
BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
|
PLoS Pathog
|
2012
|
1.01
|
|
25
|
RNAs in Epstein-Barr virions control early steps of infection.
|
Proc Natl Acad Sci U S A
|
2012
|
1.01
|
|
26
|
Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
|
J Virol
|
2003
|
0.99
|
|
27
|
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.
|
Eur J Immunol
|
2004
|
0.99
|
|
28
|
Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.
|
J Virol
|
2010
|
0.97
|
|
29
|
Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production.
|
J Virol
|
2004
|
0.97
|
|
30
|
The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
|
J Virol
|
2011
|
0.95
|
|
31
|
CMV-specific TCR-transgenic T cells for immunotherapy.
|
J Immunol
|
2009
|
0.93
|
|
32
|
A virus-like particle-based Epstein-Barr virus vaccine.
|
J Virol
|
2011
|
0.92
|
|
33
|
Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation.
|
Curr Opin Virol
|
2013
|
0.91
|
|
34
|
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
|
J Virol
|
2007
|
0.91
|
|
35
|
c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs.
|
Nucleic Acids Res
|
2013
|
0.90
|
|
36
|
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
|
PLoS One
|
2011
|
0.85
|
|
37
|
HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.
|
Eur J Immunol
|
2005
|
0.85
|
|
38
|
High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.
|
Exp Hematol
|
2003
|
0.85
|
|
39
|
Activated B cells mediate efficient expansion of rare antigen-specific T cells.
|
Hum Immunol
|
2007
|
0.83
|
|
40
|
Efficient somatic gene targeting in the lymphoid human cell line DG75.
|
Gene
|
2004
|
0.80
|
|
41
|
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.
|
Eur J Immunol
|
2005
|
0.79
|
|
42
|
Different roles of the human Orc6 protein in the replication initiation process.
|
Cell Mol Life Sci
|
2011
|
0.78
|
|
43
|
Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.
|
PLoS One
|
2008
|
0.77
|
|
44
|
Virus-specific T cells for therapy--approaches, problems, solutions.
|
Eur J Cell Biol
|
2011
|
0.77
|
|
45
|
Conditional gene vectors regulated in cis.
|
Nucleic Acids Res
|
2008
|
0.77
|
|
46
|
The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling.
|
J Gen Virol
|
2006
|
0.75
|
|
47
|
[Lifelong healing via gene transfer - reality or utopia? Stable versus transient gene transfer].
|
Pharm Unserer Zeit
|
2011
|
0.75
|